AAAAAA
Results: 1-25/44
Authors:
VOLZ HP
GLEITER CH
Citation: Hp. Volz et Ch. Gleiter, MONOAMINE-OXIDASE INHIBITORS - A PERSPECTIVE ON THEIR USE IN THE ELDERLY, Drugs & aging, 13(5), 1998, pp. 341-355
Authors:
HERMANN R
WILDGRUBE HJ
RUUS P
NIEBCH G
NOWAK H
GLEITER CH
Citation: R. Hermann et al., GASTRIC-EMPTYING IN PATIENTS WITH INSULIN-DEPENDENT DIABETES-MELLITUSAND BIOAVAILABILITY OF THIOCTIC ACID-ENANTIOMERS, European journal of pharmaceutical sciences, 6(1), 1998, pp. 27-37
Authors:
GLEITER CH
SCHREEB KH
GOLDBACH S
HERZOG S
CUNZE T
KUHN W
Citation: Ch. Gleiter et al., FENOTEROL INCREASES ERYTHROPOIETIN CONCENTRATIONS DURING TOCOLYSIS, British journal of clinical pharmacology, 45(2), 1998, pp. 157-159
Authors:
MEINEKE I
GLEITER CH
Citation: I. Meineke et Ch. Gleiter, ASSESSMENT OF DRUG ACCUMULATION IN THE EVALUATION OF PHARMACOKINETIC DATA, Journal of clinical pharmacology, 38(8), 1998, pp. 680-684
Authors:
GLEITER CH
KLOTZ U
KUHLMANN J
BLUME H
STANISLAUS F
HARDER S
PAULUS H
Citation: Ch. Gleiter et al., WHEN ARE BIOAVAILABILITY STUDIES REQUIRED - A GERMAN PROPOSAL, Journal of clinical pharmacology, 38(10), 1998, pp. 904-911
Authors:
VORMFELDE SV
MUCK W
KUHLMANN J
GLEITER CH
Citation: Sv. Vormfelde et al., DOES LOW SERUM-ALBUMIN CONCENTRATION OR CREATININE CLEARANCE PREDICT CERIVASTATIN PHARMACOKINETICS IN PATIENTS WITH RENAL IMPAIRMENT, Naunyn-Schmiedeberg's archives of pharmacology, 357(4), 1998, pp. 618-618
Authors:
FREUDENTHALER S
SCHREEB KH
KORNER T
GLEITER CH
Citation: S. Freudenthaler et al., ANGIOTENSIN-II INCREASES ERYTHROPOIETIN PRODUCTION IN HUMANS, Naunyn-Schmiedeberg's archives of pharmacology, 357(4), 1998, pp. 634-634
Authors:
FREUDENTHALER S
MEINEKE I
SCHREEB KH
GLEITER CH
Citation: S. Freudenthaler et al., PHARMACOKINETIC MODELING OF THE RENAL EXCRETION OF MEMANTINE - INFLUENCE OF URINE PH AND URINARY FLOW, Naunyn-Schmiedeberg's archives of pharmacology, 357(4), 1998, pp. 668-668
Authors:
GLEITER CH
SCHREEB KH
THOMAS M
ELZE M
FIEGERBUSCHGES H
POTTHAST H
SCHNEIDER E
BLUME HH
HERMANN R
Citation: Ch. Gleiter et al., LACK OF PHARMACOKINETIC INTERACTION BETWEEN THIOCTIC ACID, GLIBENCLAMIDE AND ACARBOSE, Naunyn-Schmiedeberg's archives of pharmacology, 357(4), 1998, pp. 669-669
Authors:
MEINEKE I
TURCK D
GLEITER CH
Citation: I. Meineke et al., POPULATION PHARMACOKINETICS OF MELOXICAM IN PATIENTS WITH RHEUMATOID ARTHRITIS-DRUG INTERACTION MODELS, Naunyn-Schmiedeberg's archives of pharmacology, 357(4), 1998, pp. 675-675
Authors:
SCHREEB KH
MEINEKE I
MEYERBARNER M
GLEITER CH
Citation: Kh. Schreeb et al., PHARMACOKINETICS OF DOXEPIN AND DESMETHYLDOXEPIN - AN EVALUATION WITHTHE POPULATION APPROACH, Naunyn-Schmiedeberg's archives of pharmacology, 357(4), 1998, pp. 684-684
Authors:
GLEITER CH
Citation: Ch. Gleiter, DRUG-INTERACTIONS - PROTON PUMP INHIBITORS (PART ONE), Der Internist, 39(8), 1998, pp. 874-875
Authors:
GLEITER CH
VOLZ HP
Citation: Ch. Gleiter et Hp. Volz, FLUOXETINE, Deutsche Medizinische Wochenschrift, 122(15), 1997, pp. 481-482
Authors:
GLEITER CH
BECKER T
WENZEL J
Citation: Ch. Gleiter et al., ERYTHROPOIETIN PRODUCTION IN HEALTHY-VOLUNTEERS SUBJECTED TO CONTROLLED HYPOBARIC HYPOXIA - FURTHER EVIDENCE AGAINST A ROLE FOR ADENOSINE, British journal of clinical pharmacology, 44(2), 1997, pp. 203-205
Authors:
VOLZ HP
GLEITER CH
MOLLER HJ
Citation: Hp. Volz et al., BROFAROMINE VERSUS IMIPRAMINE IN INPATIENTS WITH MAJOR DEPRESSION - ACONTROLLED TRIAL, Journal of affective disorders, 44(2-3), 1997, pp. 91-99
Authors:
GLEITER CH
Citation: Ch. Gleiter, PHARMACODYNAMIC METHODS - INVENTORY AND CRITICAL-APPRAISAL - 5TH ANNUAL-MEETING OF THE ASSOCIATION-OF-APPLIED-HUMAN-PHARMACOLOGY, Journal of clinical pharmacology, 37(1), 1997, pp. 1-1
Authors:
GLEITER CH
BRAUSE M
DELABAR U
ZEBSKI H
ECKARDT KU
Citation: Ch. Gleiter et al., EVIDENCE AGAINST A MAJOR ROLE OF ADENOSINE IN OXYGEN-DEPENDENT REGULATION OF ERYTHROPOIETIN IN RATS, Kidney international, 52(2), 1997, pp. 338-344
Authors:
VORMFELDE SV
BITSCH A
MEINEKE I
GUNDERTREMY UM
GLEITER CH
Citation: Sv. Vormfelde et al., NONRESPONSE TO MAPROTILINE CAUSED BY ULTRA-RAPID METABOLISM THAT IS DIFFERENT FROM CYP2D6, European Journal of Clinical Pharmacology, 52(5), 1997, pp. 387-390
Authors:
SCHREEB KH
FREUDENTHALER S
VORMFELDE SV
GUNDERTREMY U
GLEITER CH
Citation: Kh. Schreeb et al., COMPARATIVE BIOAVAILABILITY OF 2 VITAMIN-B1 PREPARATIONS - BENFOTIAMINE AND THIAMINE MONONITRATE, European Journal of Clinical Pharmacology, 52(4), 1997, pp. 319-320
Authors:
MUHLBAUER B
GLEITER CH
GIES C
LUIPPOLD G
LOSCHMANN PA
Citation: B. Muhlbauer et al., RENAL RESPONSE TO INFUSION OF DOPAMINE PRECURSORS IN ANESTHETIZED RATS, Naunyn-Schmiedeberg's archives of pharmacology, 356(6), 1997, pp. 838-845
Authors:
GLEITER CH
BECKER T
BERGENER M
SCHREEB KH
FREUDENTHALER S
GUNDERTREMY U
Citation: Ch. Gleiter et al., FENOTEROL BUT NOT DOBUTAMINE INCREASES ERYTHROPOIETIN PRODUCTION IN HUMANS, Naunyn-Schmiedeberg's archives of pharmacology, 355(4), 1997, pp. 428-428
Authors:
GLEITER CH
HEER M
BECKER T
BRAU C
GERZER R
GUNDERTREMY U
Citation: Ch. Gleiter et al., IS ADENOSINE A MODULATOR OF RENAL ERYTHROPOIETIN PRODUCTION IN HUMANSEXPOSED TO HYPOBARIC HYPOXIA, Naunyn-Schmiedeberg's archives of pharmacology, 355(4), 1997, pp. 442-442
Authors:
LOSER SV
BITSCH A
MEINEKE I
GUNDERTREMY UM
GLEITER CH
Citation: Sv. Loser et al., NONRESPONSE TO MAPROTILINE CAUSED BY ULTRARAPID METABOLISM DIFFERENT FROM CYP2D6, Naunyn-Schmiedeberg's archives of pharmacology, 355(4), 1997, pp. 457-457
Authors:
SCHREEB KH
FREUDENTHALER S
GLEITER CH
GUNDERTREMY U
Citation: Kh. Schreeb et al., RELATIVE BIOAVAILABILITY OF THE VITAMIN-B1 ANALOG BENFOTHIAM, Naunyn-Schmiedeberg's archives of pharmacology, 355(4), 1997, pp. 475-475
Authors:
VORMFELDE SV
GLEITER CH
FREUDENTHALER S
MUCK W
SCHMAGE N
KUHLMANN J
GUNDERTREMY U
Citation: Sv. Vormfelde et al., PHARMACOKINETICS OF SINGLE-DOSE CERIVASTATIN IN SUBJECTS WITH NORMAL AND IMPAIRED RENAL-FUNCTION, Atherosclerosis, 130, 1997, pp. 127-127